JPRN-jRCT2080221948未知2 期
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Exploratory Study of DSP-1747 in Patients with Nonalcoholic Steatohepatitis(Phase 2 Study)
适应症
试验速览
- 阶段
- 2 期
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 64age old（—）
- 性别
- All
入选标准
- •Patients with Nonalcoholic Steatohepatitis based on the liver biopsy
- •-Outpatients
排除标准
- •- Patients with significant alcohol consumption
- •- Patients with complication by other chronic liver disease
研究者
相似试验
进行中（未招募）
1 期
A study to investigate the safety of APD811 (study drug) and to determine the most effective dose of APD811 in patients with pulmonary arterial hypertension.Pulmonary Arterial HypertensionEUCTR2014-000667-40-PLArena Pharmaceuticals, Inc.60
招募中
2 期
A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic People With Schizophrenia, Followed by an Open-label Extension PhaseSchizophreniaJPRN-jRCT2071210003Yabuuchi Kazuki480
进行中（未招募）
1 期
A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic People With Schizophrenia, Followed by an Open-label Extension PhaseAcutely Psychotic Patients with SchizophreniaMedDRA version: 21.1Level: LLTClassification code: 10001064Term: Acute schizophrenia Class: 10037175CTIS2022-503006-20-00Sumitomo Pharma Co. Ltd.480
进行中（未招募）
1 期
A study to investigate the safety of APD811 (study drug) and to determine the most effective dose of APD811 in patients with pulmonary arterial hypertension.MedDRA version: 19.0Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersPulmonary Arterial HypertensionEUCTR2014-000667-40-HUArena Pharmaceuticals, Inc.60
进行中（未招募）
1 期
A study to investigate the safety of APD811 (study drug) and to determine the most effective dose of APD811 in patients with pulmonary arterial hypertension.Pulmonary Arterial HypertensionMedDRA version: 18.1 Level: PT Classification code 10064911 Term: Pulmonary arterial hypertension System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2014-000667-40-SKArena Pharmaceuticals, Inc.60